Topic

All

12
Feb
2019

The Immune Sequencing Frontier (Take 2): Harlan and Chad Robins on The Long Run

Today’s guests on The Long Run are Harlan and Chad Robins. They are brothers and co-founders of Seattle-based Adaptive Biotechnologies. Chad is the CEO, and Harlan is the head of innovation. Harlan is also a faculty member at the Fred Hutchinson Cancer Research Center just down the street from Adaptive. Senior people in pharma R&D are quite familiar with Adaptive....
Read More
6
Feb
2019

Get Tickets Now: The Cancer Summit Series is Coming to Boston, SF, Seattle

We live in a time of tremendous possibility for cancer R&D. Checkpoint inhibitors, cell therapies, molecular diagnostics that catch cancer early and can guide effective custom treatment – these fields are brimming with progress. All were considered speculative at best a decade ago. The science has never been more promising. Yet pricing and access to this new world of cancer...
Read More
30
Jan
2019

Finding a Way in Genomic Diagnostics: Bonnie Anderson of Veracyte on The Long Run

Bonnie Anderson is today’s guest on The Long Run. Bonnie is the CEO of Veracyte. It’s a genomic diagnostics company in South San Francisco. The company markets a line of tests for thyroid cancer, lung cancer, and idiopathic pulmonary fibrosis. Veracyte got started in 2008. Bonnie, as co-founder and CEO, was recruited by Kleiner Perkins Caufield & Byers and a...
Read More
2
Jan
2019

From Merck Fast Track to Computer Chem Frontier: Karen Akinsanya on The Long Run

Today’s guest on The Long Run is Karen Akinsanya. Karen is the chief biomedical scientist at Schrodinger. The New York-based company is a leader in computational chemistry for drug discovery. The company is privately held, and not a household name. But some wealthy and powerful people know it well. Schrodinger counts Bill Gates and David E. Shaw, the hedge fund...
Read More
26
Dec
2018

Messenger RNA Therapies That You May Not Have Heard Of: Ron Renaud on The Long Run

Today’s guest on The Long Run is Ron Renaud. Ron is the CEO of Lexington, Mass.-based Translate Bio. The company is working on messenger RNA therapies. You may have heard about this technology. mRNA molecules provide genetic instructions for making proteins. The idea is to restore functional proteins that, for one reason or another, have gone awry in a disease...
Read More